高级检索
当前位置: 首页 > 详情页

Comparative Analysis of the Efficacies in Neoadjuvant Chemotherapy of Breast Cancer

| |

文献详情

编号/登记号:
注册时间:
研究开始时间:
研究结束时间:
项目类型:
本院角色:
多中心研究:
招募状态:
试验分期:
研究疾病/适应症:
研究类型:
研究负责人:
研究单位: [1]Department of Radiotherapy, 307 Hospital of PLA [2]Harbin Medical University Cancer Hospital Harbin, Heilongjiang, China, 150081 [3]Hunan Provincial People's Hospital Changsha, Hunan, China, 410005 [4]Xiangya Hospital, Central South University Changsha, Hunan, China, 410008 [5]Jiangsu Cancer Hospital Nanjing, Jiangsu, China, 210000 [6]The fourth hospital of Hebei Medical University Shijiazhuang, Hebei, China, 050010

关键词: Breast tumor Neoadjuvant chemotherapy Pathological complete remission

研究目的:
The purpose of this study is to compare the short-term and long-term efficacies and the safeties of pirarubicin plus docetaxel(AT group) and pirarubicin plus cyclophosphamide followed by docetaxel(AC-T group) in neoadjuvant chemotherapy of breast cancer.

资源点击量:42329 今日访问量:0 总访问量:1365 更新日期:2025-08-01 建议使用谷歌、火狐浏览器 常见问题

技术支持:重庆聚合科技有限公司 地址:河北省石家庄市健康路12号